186 related articles for article (PubMed ID: 30935429)
1. Serum folate concentrations at diagnosis are associated with hepatocellular carcinoma survival in the Guangdong Liver Cancer Cohort study.
Fang AP; Liu ZY; Liao GC; Chen PY; Wang XY; Zhang DM; Luo Y; Long JA; Zhong RH; Zhou ZG; Xu YJ; Xu XJ; Ling WH; Chen MS; Zhang YJ; Zhu HL
Br J Nutr; 2019 Jun; 121(12):1376-1388. PubMed ID: 30935429
[TBL] [Abstract][Full Text] [Related]
2. Serum copper and zinc levels at diagnosis and hepatocellular carcinoma survival in the Guangdong Liver Cancer Cohort.
Fang AP; Chen PY; Wang XY; Liu ZY; Zhang DM; Luo Y; Liao GC; Long JA; Zhong RH; Zhou ZG; Xu YJ; Xu XJ; Ling WH; Chen MS; Zhang YJ; Zhu HL
Int J Cancer; 2019 Jun; 144(11):2823-2832. PubMed ID: 30426509
[TBL] [Abstract][Full Text] [Related]
3. Serum Bioavailable, Rather Than Total, 25-hydroxyvitamin D Levels Are Associated With Hepatocellular Carcinoma Survival.
Fang AP; Long JA; Zhang YJ; Liu ZY; Li QJ; Zhang DM; Luo Y; Zhong RH; Zhou ZG; Xu YJ; Xu XJ; Ling WH; Chen MS; Zhu HL
Hepatology; 2020 Jul; 72(1):169-182. PubMed ID: 31677282
[TBL] [Abstract][Full Text] [Related]
4. Global Level of Plasma DNA Methylation is Associated with Overall Survival in Patients with Hepatocellular Carcinoma.
Yeh CC; Goyal A; Shen J; Wu HC; Strauss JA; Wang Q; Gurvich I; Safyan RA; Manji GA; Gamble MV; Siegel AB; Santella RM
Ann Surg Oncol; 2017 Nov; 24(12):3788-3795. PubMed ID: 28593503
[TBL] [Abstract][Full Text] [Related]
5. Prediagnostic dietary intakes of vitamin A and β-carotene are associated with hepatocellular-carcinoma survival.
Zhang DM; Luo Y; Yishake D; Liu ZY; He TT; Luo Y; Zhang YJ; Fang AP; Zhu HL
Food Funct; 2020 Jan; 11(1):759-767. PubMed ID: 31915755
[TBL] [Abstract][Full Text] [Related]
6. Blood folate levels and risk of liver damage and hepatocellular carcinoma in a prospective high-risk cohort.
Welzel TM; Katki HA; Sakoda LC; Evans AA; London WT; Chen G; O'Broin S; Shen FM; Lin WY; McGlynn KA
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1279-82. PubMed ID: 17548697
[TBL] [Abstract][Full Text] [Related]
7. Serum choline is associated with hepatocellular carcinoma survival: a prospective cohort study.
Liu ZY; Yishake D; Fang AP; Zhang DM; Liao GC; Tan XY; Zhang YJ; Zhu HL
Nutr Metab (Lond); 2020; 17():25. PubMed ID: 32256673
[TBL] [Abstract][Full Text] [Related]
8. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
Lee S; Rhim H; Kim YS; Kang TW; Song KD
Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910
[TBL] [Abstract][Full Text] [Related]
9. Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma.
Köberle V; Kronenberger B; Pleli T; Trojan J; Imelmann E; Peveling-Oberhag J; Welker MW; Elhendawy M; Zeuzem S; Piiper A; Waidmann O
Eur J Cancer; 2013 Nov; 49(16):3442-9. PubMed ID: 23810247
[TBL] [Abstract][Full Text] [Related]
10. Prognostic utility of systemic inflammatory markers and chronic hepatitis C virus infection status in hepatocellular carcinoma patients treated with local ablation.
Ali MAM; Harmsen WS; Morsy KH; Galal GMK; Therneau TM; Roberts LR
BMC Cancer; 2022 Feb; 22(1):221. PubMed ID: 35227234
[TBL] [Abstract][Full Text] [Related]
11. High serum fibroblast growth factor 21 is associated with inferior hepatocellular carcinoma survival: A prospective cohort study.
Liu ZY; Luo Y; Fang AP; Wusiman M; He TT; Liu XZ; Yishake D; Chen S; Lu XT; Zhang YJ; Zhu HL
Liver Int; 2022 Mar; 42(3):663-673. PubMed ID: 34812573
[TBL] [Abstract][Full Text] [Related]
12. Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma.
Cabibbo G; Petta S; Barbara M; Attardo S; Bucci L; Farinati F; Giannini EG; Negrini G; Ciccarese F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Sacco R; Virdone R; Marra F; Mega A; Morisco F; Benvegnù L; Gasbarrini A; Svegliati-Baroni G; Foschi FG; Olivani A; Masotto A; Nardone G; Colecchia A; Persico M; Craxì A; Trevisani F; Cammà C;
J Hepatol; 2017 Jul; 67(1):65-71. PubMed ID: 28192185
[TBL] [Abstract][Full Text] [Related]
13. Plasma Folate and Vitamin B12 Levels in Patients with Hepatocellular Carcinoma.
Cui LH; Quan ZY; Piao JM; Zhang TT; Jiang MH; Shin MH; Choi JS
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27376276
[TBL] [Abstract][Full Text] [Related]
14. Applicability of BALAD score in prognostication of hepatitis B-related hepatocellular carcinoma.
Chan SL; Mo F; Johnson P; Li L; Tang N; Loong H; Chan AW; Koh J; Chan AT; Yeo W
J Gastroenterol Hepatol; 2015 Oct; 30(10):1529-35. PubMed ID: 25968302
[TBL] [Abstract][Full Text] [Related]
15. A novel score based on serum apolipoprotein A-1 and C-reactive protein is a prognostic biomarker in hepatocellular carcinoma patients.
Mao M; Wang X; Sheng H; Liu Y; Zhang L; Dai S; Chi PD
BMC Cancer; 2018 Nov; 18(1):1178. PubMed ID: 30486825
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors of spontaneously ruptured hepatocellular carcinoma.
Han XJ; Su HY; Shao HB; Xu K
World J Gastroenterol; 2015 Jun; 21(24):7488-94. PubMed ID: 26139994
[TBL] [Abstract][Full Text] [Related]
17. Alcohol consumption, folate intake, hepatocellular carcinoma, and liver disease mortality.
Persson EC; Schwartz LM; Park Y; Trabert B; Hollenbeck AR; Graubard BI; Freedman ND; McGlynn KA
Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):415-21. PubMed ID: 23307533
[TBL] [Abstract][Full Text] [Related]
18. Interrelationships among genetic C677T polymorphism of 5,10-methylenetetrahydrofolate reductase, biochemical folate status, and lymphocytic p53 oxidative damage in association with tumor malignancy and survivals of patients with hepatocellular carcinoma.
Kuo CS; Huang CY; Kuo HT; Cheng CP; Chen CH; Lu CL; Yang FL; Syu Huang RF
Mol Nutr Food Res; 2014 Feb; 58(2):329-42. PubMed ID: 23996892
[TBL] [Abstract][Full Text] [Related]
19. Plasma Adiponectin and Hepatocellular Carcinoma Survival Among Patients Without Liver Transplantation.
Shen J; Yeh CC; Wang Q; Gurvich I; Siegel AB; Santella RM
Anticancer Res; 2016 Oct; 36(10):5307-5314. PubMed ID: 27798893
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.
Sasaki K; Firl DJ; Hashimoto K; Fujiki M; Diago-Uso T; Quintini C; Eghtesad B; Fung JJ; Aucejo FN; Miller CM
Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):595-603. PubMed ID: 28546007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
